Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trilogy International Partners Inc T.TRL.WT.A


Primary Symbol: V.TRL.H

Trilogy International Partners Inc. operates through its subsidiary Trilogy International Partners LLC (Trilogy LLC). Prior to the disposal of its New Zealand and Bolivia operations, Trilogy LLC was a provider of wireless voice and data communications services including local, international long distance and roaming services. Trilogy LLC also provided fixed broadband communications services to residential and enterprise customers in New Zealand and Bolivia. The Company had two reportable segments identified by their geographic regions, New Zealand and Bolivia. Two Degrees Mobile Limited (2degrees) operated in New Zealand and Empresa de Telecomunicaciones NuevaTel (PCS de Bolivia), S.A. (NuevaTel) operated in Bolivia. Both these segments provided a variety of wireless voice and data communications services, including local, international long distance and roaming services. The services were provided to subscribers on both a postpaid and prepaid basis.


TSXV:TRL.H - Post by User

Comment by knollon Oct 26, 2013 6:10pm
202 Views
Post# 21851832

RE:RE:-46.00% What?

RE:RE:-46.00% What?
thought I was the only one who saw this as something postitive. My biggest concern was nothing was happening. I had images of the Trimel folder sitting on someone desk collecting dust. It was comforting to know that it was looke at and assessed. For me it was only 7 questions to clearify. It never occured to me that the FDA would not have any questions ( I renew my morgage and the itch ask me a million questions). There is nothing here to justify a 46% drop. I was expecting another flat day. Well wasn't I surprised.

This is forward movement  - it is a positive thing.

A catastroghe would be if they have to black box this. That would justify a 46% drop because something fundamentally changed about the product. No black box gives Contempo a competitive advantage. So something along that line ya 50% drop. Not 7 questions forwhich we don't even know the questions.

2.6 million shares got sold (a %age would be a short position imaging) but 2.6 million shares also got bought. For the record 6000 of those bought was me. Either I wasted another $3000 or just averaged down some.

Contempo is still going to be the best option in its class - I think I averaged down.

 

Bullboard Posts